U.K. Cannabidiol Market
U.K. Cannabidiol Market - Global Industry Assessment & Forecast
#
Pages:
180
2023
Jun - 2024
VMR-2529
Segments Covered
By
Product Oil, Tinctures, Suppository, Transdermal Patches, Isolates, Tablet, Capsules, Vape Oil, Creams and Roll-on, CBD Inhalers, Others
-
By
Application Skincare, Femcare (PMS/cramps), Mental Wellness, Disease Prevention, Sleep/Insomnia, Joint Pain & Inflammation, Chronic Pain, Neurological Conditions, Others
-
By
Route of Administration Oral, Topical, Inhalation, Rectal, Transdermal Patches, Sublingual
-
By
Source Hemp, Marijuana
-
By
Distribution Channel Hospital Pharmacies, Retail Stores, Online Pharmacies
-
By
Gender Men, Women
-
By
Age Baby Boomers (Above 55), Generation X (39 to 54), Millennials (23 to 38), Generation Z (Less than 23)
-
By
Wellness Products/Services CBD Oil, CBD Capsules, CBD Spa Treatments, CBD-infused Beverages, Others
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2030 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 1355.6 Million |
 Revenue 2030:
|
USD 5066.7 Million |
 Revenue CAGR
(2024 - 2030): |
24.58% |
Fastest Growing Region (2024 -
2030)
|
NA |
Largest Region (2023):
|
NA |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2018 to 2022 |
| 3. | Forecast Data | 2024 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
FAQ
Frequently Asked Question
What is the global demand for U.K. Cannabidiol in terms of revenue?
-
The global U.K. Cannabidiol valued at USD 1355.6 Million in 2023 and is expected to reach USD 5066.7 Million in 2030 growing at a CAGR of 24.58%.
Which are the prominent players in the market?
-
The prominent players in the market are WEECO Pharma GmbH, Bedrocan, SOMAÍ Pharmaceuticals, Little Green Pharma, DEMECAN, HAPA Pharm, The Cronos group, Pharmahemp, Medipharm labs, Herb treasurer, Elixinol, Salus bioceutical.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 24.58% between 2024 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the U.K. Cannabidiol include
- Increased consumer awareness and acceptance
Which region accounted for the largest share in the market?
-
NA was the leading regional segment of the U.K. Cannabidiol in 2023.
